{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:26:53Z","timestamp":1793608013625,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013143","name":"National Natural Science Foundation of China-Shandong Joint Fund for Marine Science Research Centers","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013143","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2025ZFJH03"],"award-info":[{"award-number":["2025ZFJH03"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172681"],"award-info":[{"award-number":["82172681"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470690"],"award-info":[{"award-number":["82470690"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2023-PT320-02"],"award-info":[{"award-number":["2023-PT320-02"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2306800"],"award-info":[{"award-number":["2023YFC2306800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013145","name":"Primary Research and Development Plan of Zhejiang Province","doi-asserted-by":"publisher","award":["2024C03149"],"award-info":[{"award-number":["2024C03149"]}],"id":[{"id":"10.13039\/501100013145","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013072","name":"Major Science and Technology Project of Hainan Province","doi-asserted-by":"publisher","award":["ZDYF2025LCLH012"],"award-info":[{"award-number":["ZDYF2025LCLH012"]}],"id":[{"id":"10.13039\/501100013072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.canlet.2026.218449","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T23:33:56Z","timestamp":1774136036000},"page":"218449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Targeting MSR1+ tumor-associated macrophages enhances the therapeutic efficacy of anti-PD-L1 in hepatocellular carcinoma by suppressing NF-\u03baB pathway activation"],"prefix":"10.1016","volume":"647","author":[{"given":"Jianpeng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8183-5120","authenticated-orcid":false,"given":"Xi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zekuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xizhi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjiang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinfen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218449_bib1","first-page":"229","volume":"vol. 74","author":"Bray","year":"2024"},{"key":"10.1016\/j.canlet.2026.218449_bib2","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2026.218449_bib3","doi-asserted-by":"crossref","DOI":"10.1159\/000547519","article-title":"Alpha-fetoprotein and des-gamma-carboxy prothrombin-based tumor marker score for first-line immunotherapy selection in hepatocellular carcinoma","author":"Tanaka","year":"2025","journal-title":"Liver Cancer"},{"key":"10.1016\/j.canlet.2026.218449_bib4","article-title":"Multicenter phase II trial of lenvatinib in patients with advanced hepatocellular carcinoma after progression on first-line atezolizumab plus bevacizumab","author":"Kim","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2026.218449_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216568","article-title":"Blocking MARCO(+) tumor-associated macrophages improves anti-PD-L1 therapy of hepatocellular carcinoma by promoting the activation of STING-IFN type I pathway","volume":"582","author":"Ding","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218449_bib6","first-page":"268","volume":"vol. 10","author":"Xu","year":"2025"},{"key":"10.1016\/j.canlet.2026.218449_bib7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12943-023-01725-x","article-title":"Roles of tumor-associated macrophages in anti-PD-1\/PD-L1 immunotherapy for solid cancers","volume":"22","author":"Zhang","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218449_bib8","first-page":"207","volume":"vol. 8","author":"Chen","year":"2023"},{"key":"10.1016\/j.canlet.2026.218449_bib9","volume":"vol. 26","author":"Matsui","year":"2025"},{"key":"10.1016\/j.canlet.2026.218449_bib10","first-page":"2413","article-title":"USP14-IMP2-CXCL2 axis in tumor-associated macrophages facilitates resistance to anti-PD-1 therapy in gastric cancer by recruiting myeloid-derived suppressor cells","volume":"44","author":"You","year":"2025"},{"key":"10.1016\/j.canlet.2026.218449_bib11","first-page":"129","volume":"vol. 42","author":"Zheng","year":"2023"},{"key":"10.1016\/j.canlet.2026.218449_bib12","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ymthe.2023.12.010","article-title":"Blockade of C5a receptor unleashes tumor-associated macrophage antitumor response and enhances CXCL9-dependent CD8(+) T cell activity","volume":"32","author":"Luan","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.canlet.2026.218449_bib13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.28873","article-title":"Expression of scavenger receptor-AI promotes alternative activation of murine macrophages to limit hepatic inflammation and fibrosis","volume":"65","author":"Labonte","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2026.218449_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1012002","article-title":"The role of macrophage scavenger receptor 1 (MSR1) in inflammatory disorders and cancer","volume":"13","author":"Gudgeon","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218449_bib15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1073\/pnas.76.1.333","article-title":"Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition","volume":"76","author":"Goldstein","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2026.218449_bib16","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/CIRCRESAHA.111.261479","article-title":"Clearance of fetuin-A--containing calciprotein particles is mediated by scavenger receptor-A","volume":"111","author":"Herrmann","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.canlet.2026.218449_bib17","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.yjmcc.2012.07.006","article-title":"Increased stability of phosphatase and tensin homolog by intermedin leading to scavenger receptor A inhibition of macrophages reduces atherosclerosis in apolipoprotein E-deficient mice","volume":"53","author":"Dai","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.canlet.2026.218449_bib18","first-page":"4895","volume":"vol. 14","author":"Onyishi","year":"2023"},{"key":"10.1016\/j.canlet.2026.218449_bib19","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jhep.2021.12.012","article-title":"Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease","volume":"76","author":"Govaere","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2026.218449_bib20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12865-015-0088-x","article-title":"Involvement of soluble scavenger receptor A in suppression of T cell activation in patients with chronic hepatitis B","volume":"16","author":"Chen","year":"2015","journal-title":"BMC Immunol."},{"key":"10.1016\/j.canlet.2026.218449_bib21","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/hep.25983","article-title":"Scavenger receptor A restrains T-cell activation and protects against concanavalin A-induced hepatic injury","volume":"57","author":"Zuo","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2026.218449_bib22","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1158\/0008-5472.CAN-06-3138","article-title":"Scavenger receptor-A negatively regulates antitumor immunity","volume":"67","author":"Wang","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218449_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-01900-4","article-title":"CD8-positive T cells and CD204-positive M2-like macrophages predict postoperative prognosis of very high-risk prostate cancer","volume":"11","author":"Yanai","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218449_bib24","first-page":"1693","article-title":"High density of CD204-positive macrophages predicts worse clinical prognosis in patients with breast cancer","volume":"108","author":"Miyasato","year":"2017"},{"key":"10.1016\/j.canlet.2026.218449_bib25","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1080\/15384047.2018.1564567","article-title":"M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression","volume":"20","author":"Zeng","year":"2019","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.canlet.2026.218449_bib26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.lungcan.2018.07.015","article-title":"The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer","volume":"123","author":"Li","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canlet.2026.218449_bib27","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jhep.2023.06.021","article-title":"Targeting N6-methyladenosine reader YTHDF1 with siRNA boosts antitumor immunity in NASH-HCC by inhibiting EZH2-IL-6 axis","volume":"79","author":"Wang","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2026.218449_bib28","first-page":"eadi2952","article-title":"Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6\/STAT3 axis","volume":"16","author":"Neo","year":"2024"},{"key":"10.1016\/j.canlet.2026.218449_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104254","article-title":"IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy","volume":"359","author":"Weber","year":"2021","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.canlet.2026.218449_bib30","first-page":"639","volume":"vol. 74","author":"Zhang","year":"2025"},{"key":"10.1016\/j.canlet.2026.218449_bib31","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.ccell.2025.07.012","article-title":"Tumor-resident probiotic Clostridium butyricum improves aPD-1 efficacy in colorectal cancer models by inhibiting IL-6-mediated immunosuppression","volume":"43","author":"Xie","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218449_bib32","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/j.ccell.2023.08.012","article-title":"The intratumor mycobiome promotes lung cancer progression via myeloid-derived suppressor cells","volume":"41","author":"Liu","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218449_bib33","first-page":"1911","volume":"vol. 11","author":"Hu","year":"2020"},{"key":"10.1016\/j.canlet.2026.218449_bib34","author":"Cheng","year":"2025"},{"key":"10.1016\/j.canlet.2026.218449_bib35","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.immuni.2020.01.014","article-title":"Blockade of the phagocytic receptor MerTK on tumor-associated macrophages enhances P2X7R-Dependent STING activation by tumor-derived cGAMP","volume":"52","author":"Zhou","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2026.218449_bib36","volume":"vol. 12","author":"Yu","year":"2025"},{"key":"10.1016\/j.canlet.2026.218449_bib37","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00262-025-04180-3","article-title":"Single-cell transcriptomic analyses provide insights into SPP1(+) TAM-mediated immune suppression and CD8(+) T cell dysfunction in lung cancer","volume":"74","author":"Almgrami","year":"2025","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.canlet.2026.218449_bib38","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","article-title":"Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.canlet.2026.218449_bib39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12943-024-02208-3","article-title":"Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy","volume":"24","author":"He","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218449_bib40","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.jhep.2022.07.029","article-title":"Combined hepatocellular-cholangiocarcinoma derives from liver progenitor cells and depends on senescence and IL-6 trans-signaling","volume":"77","author":"Rosenberg","year":"2022","journal-title":"J. Hepatol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526002120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526002120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:36:37Z","timestamp":1793604997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526002120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":40,"alternative-id":["S0304383526002120"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218449","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting MSR1+ tumor-associated macrophages enhances the therapeutic efficacy of anti-PD-L1 in hepatocellular carcinoma by suppressing NF-\u03baB pathway activation","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218449","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"218449"}}